Early trial tests new drug for stubborn lymphoma
Disease control
Completed
This study tested a new drug called ME-401 in a small group of Japanese patients with a slow-growing type of blood cancer (lymphoma) that had returned or stopped responding to other treatments. The main goal was to check the drug's safety, how the body processes it, and see if it…
Phase: PHASE1 • Sponsor: Kyowa Kirin Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC